| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
5 companies
Dimartino Rose serves as a Director at THQ and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 5 buys and 0 sells. Those positions are worth an estimated $69K at current prices.
Historically, Dimartino Rose's trades have earned a below-average insider score of 31/100 across 4 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -17.7%.
The biggest single holding is THQ (~$21K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 1,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2024 | JEQ Abrdn Japan Equity Fund, Inc. | Director | Buy | 1,000 | $6.19 | $6,190.00 | New | - | - | |
| Jul 16, 2024 | THW Abrdn World Healthcare Fund | Director | Buy | 1,000 | $13.31 | $13,310.00 | New | -1.7% | -22.5% | |
| Jul 16, 2024 | HQH Abrdn Healthcare Investors | Director | Buy | 1,000 | $18.88 | $18,880.00 | New | -1.3% | -16.8% | |
| Jul 16, 2024 | HQL Abrdn Life Sciences Investors | Director | Buy | 1,000 | $15.53 | $15,530.00 | New | -3.1% | -15.6% | |
| Jul 16, 2024 | THQ Abrdn Healthcare Opportunities Fund | Director | Buy | 1,000 | $21.30 | $21,300.00 | New | +6.3% | -15.8% |